Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,090 | 165 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $799.78 | 51 | $0 (2024) |
| Amgen Inc. | $465.43 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $311.07 | 16 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $263.49 | 11 | $0 (2024) |
| Lexicon Pharmaceuticals, Inc. | $191.01 | 13 | $0 (2024) |
| Merck Sharp & Dohme LLC | $163.91 | 9 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $142.26 | 9 | $0 (2024) |
| Kiniksa Pharmaceuticals International, plc | $125.64 | 7 | $0 (2024) |
| LANTHEUS MEDICAL IMAGING, INC. | $125.00 | 1 | $0 (2024) |
| Medtronic, Inc. | $121.79 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,430 | 74 | Novartis Pharmaceuticals Corporation ($438.26) |
| 2023 | $1,286 | 71 | Novartis Pharmaceuticals Corporation ($328.38) |
| 2022 | $374.97 | 20 | SANOFI-AVENTIS U.S. LLC ($83.56) |
All Payment Transactions
165 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: DIABETES | ||||||
| 12/04/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Cardiology | ||||||
| 11/20/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | LANTHEUS MEDICAL IMAGING, INC. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CONTRAST AGENT | ||||||
| 11/12/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Cardiology | ||||||
| 11/08/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Cardiology | ||||||
| 11/07/2024 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/16/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Cardiology | ||||||
| 10/11/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Not Applicable | ||||||
| 10/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $31.33 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/27/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Cardiology | ||||||
| 09/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: DIABETES | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | SCPHARMACEUTICALS INC. | FUROSCIX (Drug) | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Cardiology | ||||||
| 08/20/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/02/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.12 | General |
| 07/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/12/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $13.74 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 268 | 291 | $44,632 | $12,428 |
| 2022 | 7 | 353 | 386 | $37,643 | $10,833 |
| 2021 | 9 | 420 | 466 | $43,998 | $15,902 |
| 2020 | 14 | 538 | 580 | $45,066 | $14,883 |
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 149 | 165 | $42,075 | $11,485 | 27.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 16 | 17 | $510.00 | $223.04 | 43.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 36 | 36 | $1,044 | $184.78 | 17.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 16 | 16 | $368.00 | $165.60 | 45.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 22 | 26 | $156.00 | $152.88 | 98.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 15 | 15 | $255.00 | $114.15 | 44.8% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2023 | 14 | 16 | $224.00 | $102.08 | 45.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 105 | 123 | $31,021 | $8,758 | 28.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 151 | 166 | $4,822 | $1,260 | 26.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 21 | 21 | $630.00 | $278.27 | 44.2% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 18 | 18 | $414.00 | $188.26 | 45.5% |
| 82552 | Creatine kinase (cardiac enzyme) level, isoenzymes | Office | 2022 | 12 | 12 | $360.00 | $159.63 | 44.3% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2022 | 15 | 15 | $210.00 | $96.71 | 46.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 31 | 31 | $186.00 | $91.95 | 49.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 143 | 172 | $36,464 | $13,310 | 36.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 115 | 123 | $4,059 | $1,008 | 24.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 29 | 31 | $930.00 | $415.09 | 44.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2021 | 26 | 28 | $644.00 | $295.68 | 45.9% |
| 82552 | Creatine kinase (cardiac enzyme) level, isoenzymes | Office | 2021 | 21 | 22 | $660.00 | $294.58 | 44.6% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 11 | 11 | $407.00 | $184.80 | 45.4% |
| 82550 | Creatine kinase (cardiac enzyme) level, total | Office | 2021 | 22 | 23 | $322.00 | $149.73 | 46.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 16 | 16 | $272.00 | $124.32 | 45.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 37 | 40 | $240.00 | $120.00 | 50.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 113 | 144 | $30,064 | $8,987 | 29.9% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 21 | 21 | $2,757 | $1,115 | 40.5% |
About Amy Norris, PA
Amy Norris, PA is a Medical healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/03/2017. The National Provider Identifier (NPI) number assigned to this provider is 1528570249.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amy Norris, PA has received a total of $3,090 in payments from pharmaceutical and medical device companies, with $1,430 received in 2024. These payments were reported across 165 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($3,090).
As a Medicare-enrolled provider, Norris has provided services to 1,579 Medicare beneficiaries, totaling 1,723 services with total Medicare billing of $54,046. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Practice Information
- Specialty Medical
- Location Syracuse, NY
- Active Since 11/03/2017
- Last Updated 03/17/2018
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1528570249
Products in Payments
- Repatha (Biological) $465.43
- ENTRESTO (Drug) $402.22
- LEQVIO (Drug) $397.56
- JARDIANCE (Drug) $311.07
- MULTAQ (Drug) $263.49
- VERQUVO (Drug) $163.91
- Inpefa (Drug) $132.76
- Arcalyst (Drug) $125.64
- DEFINITY (Drug) $125.00
- FARXIGA (Drug) $112.54
- AZURE XT DR MRI SURESCAN (Device) $103.24
- FUROSCIX (Drug) $66.58
- LifeVest (Device) $58.56
- ELIQUIS (Drug) $49.51
- Assure WCD (Device) $49.24
- WATCHMAN Access System (Device) $37.66
- VYNDAQEL (Drug) $37.40
- BRILINTA (Drug) $29.72
- PRALUENT (Biological) $18.90
- LINQ II (Device) $18.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Medical Doctors in Syracuse
Vincent Gemelli, Pa, PA
Medical — Payments: $13,328
Madeline Farchione, Pa-C, PA-C
Medical — Payments: $7,601
Colin King
Medical — Payments: $7,380
Mrs. Angela Simione Albino, Pa, PA
Medical — Payments: $5,247
Jessica Ripic, Pa, PA
Medical — Payments: $4,771
Jason Falcone, Rpa-C, RPA-C
Medical — Payments: $4,552